These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 6504706)
21. Possible relationship between pyrido-pyrrolo-isoquinoline derivative (BD-40) cell uptake and cell viability. Vilarem MJ; Gras MP; Rivalle C; Larsen CJ Biochimie; 1982 Oct; 64(10):923-32. PubMed ID: 6817823 [TBL] [Abstract][Full Text] [Related]
22. Ellipticine binds to a human telomere sequence: an additional mode of action as a putative anticancer agent? Ghosh S; Kar A; Chowdhury S; Dasgupta D Biochemistry; 2013 Jun; 52(24):4127-37. PubMed ID: 23697684 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of human DNA topoisomerase IIα by two novel ellipticine derivatives. Vann KR; Ergün Y; Zencir S; Oncuoglu S; Osheroff N; Topcu Z Bioorg Med Chem Lett; 2016 Apr; 26(7):1809-12. PubMed ID: 26906637 [TBL] [Abstract][Full Text] [Related]
24. Differential inhibition by an antitumoral drug 10-[gamma-diethylaminopropylamino]-6-methyl-5H-pyrido[3',4': 4,5]pyrrolo [2,3-G]isoquinoline (BD-40), a pyrido-pyrrolo-isoquinoline derivative, of in vitro DNA synthesis catalyzed by various DNA polymerases. Ono K; Nakane H; Barre-Sinoussi F; Chermann JC Cancer Lett; 1990 May; 51(1):59-65. PubMed ID: 1692511 [TBL] [Abstract][Full Text] [Related]
26. Protein-associated DNA breaks in cells treated with adriamycin or ellipticine. Ross WE; Glaubiger DL; Kohn KW Biochim Biophys Acta; 1978 Jun; 519(1):23-30. PubMed ID: 566561 [TBL] [Abstract][Full Text] [Related]
27. The anticancer agent ellipticine unwinds DNA by intercalative binding in an orientation parallel to base pairs. Canals A; Purciolas M; Aymamí J; Coll M Acta Crystallogr D Biol Crystallogr; 2005 Jul; 61(Pt 7):1009-12. PubMed ID: 15983425 [TBL] [Abstract][Full Text] [Related]
28. Changing a leucine to a lysine residue makes NaeI endonuclease hypersensitive to DNA intercalative drugs. Jo K; Topal MD Biochemistry; 1996 Aug; 35(31):10014-8. PubMed ID: 8756463 [TBL] [Abstract][Full Text] [Related]
29. [Syntheses designed to produce 8-amino ellipticine. Synthesis and pharmacological properties of 8-nitro ellipticine]. Gansser C; Lévque X; Plat M; Viel C Farmaco Sci; 1982 May; 37(5):283-97. PubMed ID: 7095141 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and antiproliferative activity of some ellipticine-like 11H-pyrido[a]carbazole derivatives. Ferlin MG; Gia O; Dalla Via L ChemMedChem; 2011 Oct; 6(10):1872-83. PubMed ID: 21826796 [TBL] [Abstract][Full Text] [Related]
31. Diepoxybutane induces the formation of DNA-DNA rather than DNA-protein cross-links, and single-strand breaks and alkali-labile sites in human hepatocyte L02 cells. Wen Y; Zhang PP; An J; Yu YX; Wu MH; Sheng GY; Fu JM; Zhang XY Mutat Res; 2011 Nov; 716(1-2):84-91. PubMed ID: 21893073 [TBL] [Abstract][Full Text] [Related]
32. Ellipticine increases the superhelical density of intracellular SV40 DNA by intercalation. Chu Y; Hsu MT Nucleic Acids Res; 1992 Aug; 20(15):4033-8. PubMed ID: 1324474 [TBL] [Abstract][Full Text] [Related]
33. [In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship]. Fossé P; Charra M; Paoletti C; Saucier JM; René B Bull Cancer; 1994 Mar; 81(3):194-202. PubMed ID: 7894127 [TBL] [Abstract][Full Text] [Related]
34. Antitumoral activity of dipyrido [4,3-b] [3,4-f] indoles on L 1210 leukemia. Lidereau R; Chermann JC; Gruest J; Montagnier L; Ducrocq C; Rivalle C; Bisagni E Bull Cancer; 1980; 67(1):1-8. PubMed ID: 7362880 [TBL] [Abstract][Full Text] [Related]
35. Effects of ellipticine on cell survival and cell cycle progression in cultured mammalian cells. Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR Cancer Res; 1980 Jul; 40(7):2390-9. PubMed ID: 6155993 [TBL] [Abstract][Full Text] [Related]
36. Binding to DNA, cellular uptake and biological activity of a distamycin-ellipticine hybrid molecule. Bailly C; Leclere V; Pommery N; Colson P; Houssier C; Rivalle C; Bisagni E; Hénichart JP Anticancer Drug Des; 1993 Apr; 8(2):145-64. PubMed ID: 8494604 [TBL] [Abstract][Full Text] [Related]
37. Cytotoxicity of and DNA adduct formation by ellipticine and its micellar form in human leukemia cells in vitro. Stiborova M; Manhartova Z; Hodek P; Adam V; Kizek R; Eckschlager T; Frei E Neuro Endocrinol Lett; 2015; 36 Suppl 1():22-8. PubMed ID: 26757112 [TBL] [Abstract][Full Text] [Related]
38. In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia. Andersson BS; Beran M; Bakic M; Silberman LE; Newman RA; Zwelling LA Cancer Res; 1987 Feb; 47(4):1040-4. PubMed ID: 3026621 [TBL] [Abstract][Full Text] [Related]
39. Intercalative binding to DNA of new antitumoral agents: dipyrido [4,3-b] [3,4-f] indoles. Tourbez-Perrin M; Pochon F; Ducrocq C; Rivalle C; Bisagni E Bull Cancer; 1980; 67(1):9-13. PubMed ID: 7362892 [TBL] [Abstract][Full Text] [Related]
40. Rescue of mutant p53 transcription function by ellipticine. Peng Y; Li C; Chen L; Sebti S; Chen J Oncogene; 2003 Jul; 22(29):4478-87. PubMed ID: 12881704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]